your clinicians instructions always come first
He added, As with all obesity treatments, including medications and bariatric surgery, long-term success depends on integrating these interventions with healthy eating, regular physical activity, and ongoing behavioral support. Other reasons to stop semaglutide treatment include being unable to tolerate side effects, taking a contraindicated medication, or being unable to sustain long-term use financially
Healthcare providers should assess for conditions that increase appetite, including uncontrolled diabetes (check HbA1c), thyroid disorders (TSH, free T4), and psychiatric conditions
Clinical trials for semaglutide began in the early 2010s, with the SUSTAIN phase 3 trial program enrolling patients starting in 2012
Effects of Exogenous Glucagon-Like Peptide-1 on Gastric Emptying and Glucose Absorption in the Critically Ill: Relationship to Glycemia